Correlation Between Innate Pharma and AB Science

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and AB Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and AB Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and AB Science SA, you can compare the effects of market volatilities on Innate Pharma and AB Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of AB Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and AB Science.

Diversification Opportunities for Innate Pharma and AB Science

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Innate and AB Science is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and AB Science SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AB Science SA and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with AB Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AB Science SA has no effect on the direction of Innate Pharma i.e., Innate Pharma and AB Science go up and down completely randomly.

Pair Corralation between Innate Pharma and AB Science

Assuming the 90 days trading horizon Innate Pharma is expected to generate 1.33 times more return on investment than AB Science. However, Innate Pharma is 1.33 times more volatile than AB Science SA. It trades about -0.23 of its potential returns per unit of risk. AB Science SA is currently generating about -0.32 per unit of risk. If you would invest  172.00  in Innate Pharma on August 31, 2024 and sell it today you would lose (28.00) from holding Innate Pharma or give up 16.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Innate Pharma  vs.  AB Science SA

 Performance 
       Timeline  
Innate Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innate Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
AB Science SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AB Science SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Innate Pharma and AB Science Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innate Pharma and AB Science

The main advantage of trading using opposite Innate Pharma and AB Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, AB Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AB Science will offset losses from the drop in AB Science's long position.
The idea behind Innate Pharma and AB Science SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal